Hizentra® is the first and only immune globulin (Ig) available in prefilled syringes, offering those living with Primary Immunodeficiency (PI) or Chronic Inflammatory Demyelinating Polyneuropathy ...

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration has approved a subcutaneous ...

SAN DIEGO--(BUSINESS WIRE)--CeleCor Therapeutics, Inc. today announced preliminary positive results in the company’s ongoing phase 1 clinical study with RUC-4, a novel subcutaneous platelet GPIIb/IIIa ...

The benefit of reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) as salvage treatment for relapsing multiple myeloma (MM) Bortezomib (Bz) is a novel proteasome ...

--The world's first and only wearable, disposable automatic delivery system for self-administration of drugs with dose volumes 5mL or larger --Now available to pharmaceutical companies for use in drug ...

The committee recommended Keytruda's subcutaneous form for all indications and as neoadjuvant/adjuvant treatment in PD-L1-positive head and neck cancer.

All investigators agree that the method has high merit as an emergency procedure in cases of peripheral vascular collapse, inaccessible veins, as in severe burns or venous thrombosis, very restless or ...

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License ...

This column provides an overview of restraint in psittacine birds and administration of subcutaneous fluids and intramuscular injections. The principles described here may be also used on other ...

May 19, 2010 — A voluntary recall has been issued for all lots of Baxter's hyaluronidase human injection (Hylenex) because of the presence of particulate matter, identified as glass, according to a ...